Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.675
Bid: 1.65
Ask: 1.70
Change: 0.00 (0.00%)
Spread: 0.05 (3.03%)
Open: 1.675
High: 1.725
Low: 1.625
Prev. Close: 1.675
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Elixirr buys in US; JPMorgan Russian wary of values

Fri, 18th Mar 2022 20:28

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

JPMorgan Russian Securities PLC - Russia-focused investor - Net asset value per share ends Thursday at 40.3 pence. "Due to the continued closure of the Moscow Exchange (MOEX), the company considers that there has been a material change to the market value of its investments and it is in the best interests of the shareholders to apply an alternative valuation method," it adds. Continues: "While the company has applied a fair value against these investments, there is no certainty that any value will be achievable from them over the short, medium or even long term due to the factors arising following the imposition of additional sanctions against Russia."

----------

Duke Royalty Ltd - Guernsey-based royalty finance provider - Makes follow-on investment of CAD10.3 million, about GBP6.2 million, into its existing royalty partner Creo-Tech Industrial Group Inc. Creo-Tech is a Canadian holding company that acquires businesses within the engineering, procurement and construction sector in both commercial and industrial settings.

----------

Impact Healthcare REIT PLC - London-based real estate investment trust focused on healthcare properties - Invests in two care homes which were owned and operated by Woodleigh Care whose owners are retiring from the care home business. "Both homes will be operated by an existing group tenant, Welford Healthcare, and are in Mansfield, Nottinghamshire, offering 107 high quality predominantly en-suite beds, located within established residential areas," company says. Will pay GBP11.1 million for the investment, made initially by way of a loan to Welford Healthcare, which will allow it to complete the acquisition of Woodleigh Care immediately. Company adds: "The structure creates several benefits for all stakeholders, including enabling Welford Healthcare to take immediate operational control of the homes, thereby avoiding a potentially lengthy transition period while regulatory approvals are sought to register the operation of the homes in new legal entities, as well as other financial and operational efficiencies." Initial rent under the new leases is set at GBP713,750, reflecting a gross initial yield of 6.4%. Based on the homes' current trading performance, rent cover is expected to be greater than 2.0 times.

----------

Elixirr International PLC - London-based management consultancy - Acquires entire issued share capital of technology and data firm iOLAP Inc for a maximum total consideration of USD40.0 million. "The acquisition brings specialist data and analytics capabilities, including artificial intelligence and machine learning, into Elixirr where there is existing demand for these services. This will enable Elixirr to form even stronger and longer-term relationships with its existing clients as they work together on their toughest business challenges," company says. Deal consists of initial cash consideration of USD25.2 million, plus earn out payments of up to USD14.8 million. Also updates its annual outlook due to acquisition. Now guides for financial 2022 revenue in the range of GBP70 million to GBP75 million, up sharply from GBP30.3 million a year prior.

----------

CentralNic Group PLC - London-based online marketing services - Raises gross proceeds of GBP3.0 million from open offer. Issues 795,925 shares in open offer, and will now have 288.7 million shares in issue. Chief Executive Ben Crawford says: "We are grateful for the outstanding support from our institutional and retail shareholders during these challenging times. We are convinced that the proven resilience of CentralNic's businesses, built on recurring revenue models and supported by strong long term fundamental trends, will continue to drive increased shareholder value moving forward."

----------

Airea PLC - West Yorkshire-based floor coverings manufacturer - Says Chief Executive Neil Rylance will be taking a leave of absence with immediate effect due to ill health. Group Finance Director Ryan Thomas will assume the CEO role while Rylance steps aside.

----------

Genedrive PLC - Manchester-based molecular diagnostics company - Sees first six installations of the its MT-RNR1 Antibiotic Induced Hearing Loss system deployed to Manchester University NHS Foundation Trust, with four installations for Saint Mary's Hospital and two at Wythenshawe Hospital. The MT-RNR1 system screens infants in an urgent care setting for a genetic mutation that will cause lifelong hearing loss.

----------

MP Evans Group PLC - producer of palm oil in Indonesia - Notes Indonesian government increases its palm-oil export levy following the recent record-high prices. Export levy now USD200 per tonne. "The Indonesian government had recently introduced a domestic market obligation to subsidise local palm-oil supplies, but this is being withdrawn and replaced with the revised levy," company says. Also says it continues to receive strong pricing for its crude palm oil. Sees USD1,080 per tonne achieved for a tender on Friday, similar to pricing achieved just before the levy's introduction and significantly higher than the 2021 average of USD810 per tonne.

----------

MetalNRG PLC - London-based investor in natural resources and energy - Defendants in civil proceedings in English High Court requests further extension for the filing of defences. "MNRG remains focused on receipt of the defences in this case and has accordingly consented to the Defendants making the application for a further extension," company explains. Extension agreed to March 22. In January, company said it served civil legal proceedings in the English High Court against defendants - Brit ENERGY Holdings LLP, Pierpaolo Rocco and BritNRG Ltd - for a declaration and the recovery of monies paid to the LLP in 2021.

----------

W Resources PLC - London-based tin and gold mining company with projects focused in Spain and Portugal - Production at the La Parrilla mine in Spain has now restarted after maintenance shutdown on February 15. There was no production in February other than small quantities of work in progress that were reprocessed during early February. Company says: "The initial maintenance shutdown was scheduled for two weeks, and in that period further improvements were identified, delaying the restart in addition to the company evaluating options regarding the liquefied natural gas supply, following the 425% price increase announced last month."

----------

Lekoil Ltd - London-based oil and gas exploration and production company with projects focused in Nigeria and West Africa - Notes Lekoil Nigeria has suspended its decision to buy shares in Lekoil Ltd. The decision was made after Grand Court of the Cayman Islands to discharge the injunction it had previously granted against Lekoil Ltd following an application brought by Lekoil Nigeria's CEO Olalekan Akinyanmi. On December 15, Lekoil Nigeria - in which Lekoil Ltd holds a 40% interest - proposed to acquire all shares in Lekoil Ltd for 1.9 pence per share, a 100% premium to the company's trading price before its suspension on October 1.

----------

Bushveld Minerals Ltd - vanadium producer in South Africa - Agrees to a further extension with London-listed Mustang Energy PLC for the notice date to exercise the backstop on the USD8.0 million convertible loan notes owed. Date is now next Wednesday. Mustang will now have until then to extend the maturity date of the convertible loan notes.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
7 Oct 2019 11:59

NHS Ethics Approval Granted For Genedrive MT-RNR1 Screening Test Trial

NHS Ethics Approval Granted For Genedrive MT-RNR1 Screening Test Trial

Read more
3 Oct 2019 11:00

Genedrive Outlook Positive As Revenue Up And Loss Narrows In Full Year

Genedrive Outlook Positive As Revenue Up And Loss Narrows In Full Year

Read more
3 Oct 2019 10:41

Genedrive loss narrowed after double-digit revenue rise

(Sharecast News) - Genedrive on Thursday reported a narrowed annual loss as revenues jumped as its commercial relationship with the US department of defense (DoD) exceeded expectations.

Read more
9 Jul 2019 10:54

Genedrive Revenue To Suffer On Lower Uptake Of Hepatitis Test Kits

(Alliance News) - Shares in Genedrive PLC fell Tuesday after the company warned that it will miss market expectations for 2020 financial year revenue due to slower than expected uptake of the HCV

Read more
28 Mar 2019 10:36

Genedrive Interim Loss Narrows As It Continues Focus On Hepatitis

LONDON (Alliance News) - Genedrive PLC on Thursday reported a reduction in its interim loss, as it continues to progress its hepatitis testing product.For the six months to the end of 2018,

Read more
28 Mar 2019 07:59

Genedrive losses narrow despite increased R&D costs

(Sharecast News) - Molecular diagnostics company Genedrive saw revenues tick ahead slightly in the first half of its financial year but increased research and development costs kept the firm in the red.

Read more
15 Jan 2019 12:44

Genedrive Interim Revenue Rises On US And UK Government Contracts

LONDON (Alliance News) - Genedrive PLC said Tuesday it increased its first-half income and made "good progress" on two UK government funded projects.For the six months to the end

Read more
15 Jan 2019 10:17

Genedrive makes progress with HCV kit in first half

(Sharecast News) - Near-patient molecular diagnostics company Genedrive issued an unaudited update for the six months ended 31 December on Tuesday, reporting revenue of £1.5m, up from £1.3m year-on-year.

Read more
10 Dec 2018 16:23

BGF Investment Management Now Owns 12.8% Stake In Genedrive (ALLISS)

LONDON (Alliance News) - Genedrive PLC said Monday that BGF Investment Management Ltd now owns a 12.8% stake in the company.BGF's stake in the firm prior to Monday's deal, if any,

Read more
29 Nov 2018 13:56

Genedrive To Participate In Study For Use Of HCV Assay In Pharmacies

LONDON (Alliance News) - Genedrive PLC on Thursday said it will participate in an international multicentre trial to assess the impact of out-reach HCV diagnostics and therapy in a pharmacy versus

Read more
29 Nov 2018 11:49

Genedrive to participate in three-country HCV therapy study

(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Thursday that it will participate in an international multicentre trial, designed to assess the impact of outreach HCV diagnostics and therapy in a pharmacy setting when compared conventional treatment pathways.

Read more
22 Aug 2018 11:17

Genedrive Appoints Chris Yates As Non-Executive Director

LONDON (Alliance News) - Diagnostics company Genedrive PLC said Wednesday it appointed Chris Yates as non-executive director with immediate effect.Yates has been Chief Executive Officer of

Read more
8 Aug 2018 12:05

Genedrive Partners With FIND To Evaluate Its Hepatitis C Virus Kit

LONDON (Alliance News) - Genedrive PLC said Wednesday it partnered with the Foundation for Innovation of New Diagnostics, or FIND, which will evaluate its hepatitis C virus kit.The kit is a

Read more
20 Jun 2018 09:57

Genedrive Given Grant For NHS Point-Of-Care Test Development

LONDON (Alliance News) - Genedrive PLC's said Wednesday it was awarded a multi-partner grant to develop a pharmacogenetic test to fight antibiotic-related hearing loss in newborn molecular was

Read more
14 May 2018 18:07

Genedrive To Sell Two Divisions For Up To GBP1.9 Million In Cash

LONDON (Alliance News) - Genedrive PLC said Monday it proposed the disposal of the its contract research and pharmacogenomics divisions for up to GBP1.9 million in cash to biotechnology company 2

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.